1. Home
  2. SWTX vs CXW Comparison

SWTX vs CXW Comparison

Compare SWTX & CXW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SWTX
  • CXW
  • Stock Information
  • Founded
  • SWTX 2017
  • CXW 1983
  • Country
  • SWTX United States
  • CXW United States
  • Employees
  • SWTX N/A
  • CXW N/A
  • Industry
  • SWTX Biotechnology: Pharmaceutical Preparations
  • CXW Real Estate Investment Trusts
  • Sector
  • SWTX Health Care
  • CXW Real Estate
  • Exchange
  • SWTX Nasdaq
  • CXW Nasdaq
  • Market Cap
  • SWTX 2.2B
  • CXW 2.4B
  • IPO Year
  • SWTX 2019
  • CXW 1997
  • Fundamental
  • Price
  • SWTX $36.45
  • CXW $21.36
  • Analyst Decision
  • SWTX Strong Buy
  • CXW Buy
  • Analyst Count
  • SWTX 5
  • CXW 3
  • Target Price
  • SWTX $65.40
  • CXW $24.67
  • AVG Volume (30 Days)
  • SWTX 1.3M
  • CXW 1.8M
  • Earning Date
  • SWTX 11-12-2024
  • CXW 11-06-2024
  • Dividend Yield
  • SWTX N/A
  • CXW N/A
  • EPS Growth
  • SWTX N/A
  • CXW 17.92
  • EPS
  • SWTX N/A
  • CXW 0.67
  • Revenue
  • SWTX $135,487,000.00
  • CXW $1,973,599,000.00
  • Revenue This Year
  • SWTX $3,498.68
  • CXW $2.66
  • Revenue Next Year
  • SWTX $98.08
  • CXW N/A
  • P/E Ratio
  • SWTX N/A
  • CXW $31.81
  • Revenue Growth
  • SWTX N/A
  • CXW 5.16
  • 52 Week Low
  • SWTX $20.19
  • CXW $10.74
  • 52 Week High
  • SWTX $53.92
  • CXW $24.99
  • Technical
  • Relative Strength Index (RSI)
  • SWTX 71.38
  • CXW 71.30
  • Support Level
  • SWTX $29.53
  • CXW $12.66
  • Resistance Level
  • SWTX $35.26
  • CXW $24.99
  • Average True Range (ATR)
  • SWTX 1.92
  • CXW 1.31
  • MACD
  • SWTX 0.74
  • CXW 0.59
  • Stochastic Oscillator
  • SWTX 87.38
  • CXW 70.56

About SWTX SpringWorks Therapeutics Inc.

SpringWorks Therapeutics Inc is a clinical stage biopharmaceutical company applying a precision medicine approach to acquiring, developing and commercializing life-changing medicines for underserved patient populations suffering from devastating rare diseases and cancer. The company has a differentiated portfolio of small molecule targeted oncology product candidates and is advancing two potentially registrational clinical trials in rare tumor types, as well as several other programs addressing highly prevalent, genetically defined cancers.

About CXW CoreCivic Inc.

CoreCivic Inc is an owner and operator of private prisons and detention centers in the United States. It operates in three segments: Safety, Community, and Properties. The Community segment owns and operates residential reentry centers. The Properties segment owns properties for lease to third parties and government agencies. The vast majority of the company's revenue comes from the CoreCivic Safety segment which consists of correctional and detention facilities that are owned, or controlled via a long-term lease, and managed by the company, as well as those correctional and detention facilities owned by third parties but managed by CoreCivic.

Share on Social Networks: